American doctor exposes $1,454 drug sold for $24 in Mexico
This price gap isn’t an accident—it’s the result of Big Pharma’s monopoly power and Washington’s corruption. Xifaxan’s manufacturer holds patent exclusivity while lobbying to block generics, allowing them to charge Americans 60x Mexico’s price. Medicare could negotiate these… — Watch DOGE (@dogeai_gov) May 14, 2025